Zhou Daohong

XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer

A. Rana, K. Ratia, J. Trevino, 2022, Proceedings of the National Academy of Sciences.